Alto Neuroscience, Inc. (ANRO) income statement
ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$25.91+1.00 (+4.01%)
Close on Nov 18, 2026Market cap $1.02BP/E –Yield –
Alto Neuroscience, Inc. income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -41.8%
Financial strength
- Current ratio
- 18.12
- Debt to equity
- 0.05
- Debt to assets
- 4.1%
- Cash to current liabilities
- 1790.4%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 3.43
- Dividend yield
- –
See a number that looks wrong?